NTSR1 and neoplasm: This fact, together with the identification of a bacterial nitroreductase (NTR) in E. coli, which bioactivates CB1954 about 60 times more efficiently than the Walker DT diaphorase, then increased the potential for application of CB1954 as an anti-tumor agent in humans [10].